NOX 14.3% 8.0¢ noxopharm limited

Ann: US FDA grants Orphan Drug Designation for CRO-67, page-2

  1. 6,156 Posts.
    lightbulb Created with Sketch. 1208
    The apparently very short time interval between NOX reporting the preliminary results for treatment of pancreatic cancer and FDA Orphan drug status is remarkable. Looks like the FDA sees this treatment as a potential significant breakthrough and have wasted no time in granting the Orphan Status
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.010(14.3%)
Mkt cap ! $23.37M
Open High Low Value Volume
7.0¢ 8.0¢ 7.0¢ $4.207K 56.02K

Buyers (Bids)

No. Vol. Price($)
1 118527 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.